
Microbot Medical Inc
MBOTNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$1.94
Day High
$2.18
Day Low
$1.91
Prev. Close
$1.93
VolumeShares traded today.
3.50M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$136.34M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-7.34
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$4.67
52W LowLowest price over the past 52 weeks.
$1.60
50D MAAverage closing price over the last 50 trading days.
$2.20
200D MAAverage closing price over the last 200 trading days.
$2.47
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+14.0%1M
-0.5%6M
+8.0%YTD
-3.8%1Y
-20.1%About
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
www.microbotmedical.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade MBOT
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.